Non-Invasive Biomarkers of NASH

Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

BUNION

Apply to participate in a study of an investigational pain medication following a bunion removal.

KNEE REPLACEMENT

Apply to participate in a study of an investigational pain medication following a knee replacement.